Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $537.80 million. The enterprise value is $409.99 million.
Important Dates
The last earnings date was Monday, March 9, 2026, after market close.
| Earnings Date | Mar 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 58.71 million shares outstanding. The number of shares has increased by 23.81% in one year.
| Current Share Class | 58.71M |
| Shares Outstanding | 58.71M |
| Shares Change (YoY) | +23.81% |
| Shares Change (QoQ) | +4.92% |
| Owned by Insiders (%) | 1.45% |
| Owned by Institutions (%) | 59.45% |
| Float | 54.41M |
Valuation Ratios
The trailing PE ratio is 6.79 and the forward PE ratio is 18.82.
| PE Ratio | 6.79 |
| Forward PE | 18.82 |
| PS Ratio | 5.05 |
| Forward PS | 3.58 |
| PB Ratio | 3.37 |
| P/TBV Ratio | 3.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 5.28 |
| EV / Sales | 3.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.68, with a Debt / Equity ratio of 0.41.
| Current Ratio | 5.68 |
| Quick Ratio | 5.46 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 92.54 |
| Debt / FCF | n/a |
| Interest Coverage | -0.53 |
Financial Efficiency
Return on equity (ROE) is 85.66% and return on invested capital (ROIC) is -35.00%.
| Return on Equity (ROE) | 85.66% |
| Return on Assets (ROA) | -1.14% |
| Return on Invested Capital (ROIC) | -35.00% |
| Return on Capital Employed (ROCE) | -1.72% |
| Weighted Average Cost of Capital (WACC) | 9.69% |
| Revenue Per Employee | $1.75M |
| Profits Per Employee | $1.27M |
| Employee Count | 61 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 8.89 |
Taxes
In the past 12 months, ZVRA has paid $3.45 million in taxes.
| Income Tax | 3.45M |
| Effective Tax Rate | 3.98% |
Stock Price Statistics
The stock price has increased by +16.69% in the last 52 weeks. The beta is 0.94, so ZVRA's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +16.69% |
| 50-Day Moving Average | 9.09 |
| 200-Day Moving Average | 9.49 |
| Relative Strength Index (RSI) | 47.47 |
| Average Volume (20 Days) | 1,505,657 |
Short Selling Information
The latest short interest is 4.72 million, so 8.04% of the outstanding shares have been sold short.
| Short Interest | 4.72M |
| Short Previous Month | 5.41M |
| Short % of Shares Out | 8.04% |
| Short % of Float | 8.67% |
| Short Ratio (days to cover) | 3.42 |
Income Statement
In the last 12 months, ZVRA had revenue of $106.47 million and earned $77.59 million in profits. Earnings per share was $1.35.
| Revenue | 106.47M |
| Gross Profit | 89.99M |
| Operating Income | -4.23M |
| Pretax Income | 86.68M |
| Net Income | 77.59M |
| EBITDA | -179,000 |
| EBIT | -4.23M |
| Earnings Per Share (EPS) | $1.35 |
Full Income StatementBalance Sheet
The company has $191.01 million in cash and $63.21 million in debt, with a net cash position of $127.81 million or $2.18 per share.
| Cash & Cash Equivalents | 191.01M |
| Total Debt | 63.21M |
| Net Cash | 127.81M |
| Net Cash Per Share | $2.18 |
| Equity (Book Value) | 154.66M |
| Book Value Per Share | 2.72 |
| Working Capital | 183.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.60 million and capital expenditures -$835,000, giving a free cash flow of -$2.43 million.
| Operating Cash Flow | -1.60M |
| Capital Expenditures | -835,000 |
| Depreciation & Amortization | 4.05M |
| Net Borrowing | -372,000 |
| Free Cash Flow | -2.43M |
| FCF Per Share | -$0.04 |
Full Cash Flow StatementMargins
Gross margin is 84.52%, with operating and profit margins of -3.98% and 78.17%.
| Gross Margin | 84.52% |
| Operating Margin | -3.98% |
| Pretax Margin | 81.41% |
| Profit Margin | 78.17% |
| EBITDA Margin | -0.17% |
| EBIT Margin | -3.98% |
| FCF Margin | n/a |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.81% |
| Shareholder Yield | -23.81% |
| Earnings Yield | 14.43% |
| FCF Yield | -0.45% |
Analyst Forecast
The average price target for ZVRA is $23.00, which is 151.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.00 |
| Price Target Difference | 151.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 30.42% |
| EPS Growth Forecast (5Y) | 22.31% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 1:16.
| Last Split Date | Dec 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
ZVRA has an Altman Z-Score of 1.29 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.29 |
| Piotroski F-Score | 4 |
